Clinical Trials
3 trialsNCT00820547 2019-10-22
Beverly1
UNICANCER
Phase 2 Completed
NCT00301925 2018-08-08
TACT2
Institute of Cancer Research, United Kingdom
Phase 3 Unknown
NCT00176488 2017-03-23
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated